 Quest Diagnostics Inc. DGX, -2.25 reported Thursday third-quarter profit and revenue that fell from a year ago but beat expectations, as base business performance rebounding in the latter part of the quarter to help offset inflationary pressure and declining COVID-19 volumes. The health diagnostics information services companys stock was still inactive in the premarket. 